KPIs & Operating Metrics(New)
Growth Metrics

Cvs Health (CVS) Long-Term Investments (2016 - 2025)

Cvs Health (CVS) has disclosed Long-Term Investments for 9 consecutive years, with $32.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Investments rose 12.91% year-over-year to $32.7 billion, compared with a TTM value of $32.7 billion through Dec 2025, up 12.91%, and an annual FY2025 reading of $32.7 billion, up 12.91% over the prior year.
  • Long-Term Investments was $32.7 billion for Q4 2025 at Cvs Health, down from $33.7 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $33.7 billion in Q3 2025 and bottomed at $20.6 billion in Q3 2022.
  • Average Long-Term Investments over 5 years is $26.4 billion, with a median of $25.5 billion recorded in 2021.
  • The sharpest move saw Long-Term Investments soared 43.79% in 2021, then decreased 18.99% in 2022.
  • Year by year, Long-Term Investments stood at $26.1 billion in 2021, then dropped by 8.61% to $23.9 billion in 2022, then decreased by 3.65% to $23.0 billion in 2023, then grew by 25.7% to $28.9 billion in 2024, then grew by 12.91% to $32.7 billion in 2025.
  • Business Quant data shows Long-Term Investments for CVS at $32.7 billion in Q4 2025, $33.7 billion in Q3 2025, and $29.9 billion in Q2 2025.